Search

You searched for "dysfunction"

540 results found

Outcome analysis of paediatric pyeloplasty

1 January 2017 | | URO - Paediatric Urology
This prospective study from India included 744 patients of whom 112 had renal function less than or equal to 20% at the time of diagnosis. Thirty percent underwent a nephrostomy initially. Ten with no function had a nephrectomy. Of the...

Congenital buried penis – an extremely rare entity

21 August 2024 | | URO - Paediatric Urology, URO - Functional / Reconstructive Urology, URO - Trauma & Emergency
Congenital non-visualisation of penis is a rare form of buried penis. It affects the functional and psychological behaviour of the affected child. Most of the cases in literature are secondary in nature like post circumcision, post trauma and due to...

The impact of FGM on the genitourinary system: a 2021 perspective

3 March 2021 | | URO - Functional / Reconstructive Urology, URO - Trauma & Emergency
Awareness of female genital mutilation (FGM) in European countries has increased over recent decades as a result of globalisation and migration of populations. The World Health Organization (WHO) describes FGM as procedures that involve partial or total removal of the...

Introduction to prostate cryotherapy

1 May 2015 | | URO - Urologic Oncology
Introduction Cryotherapy was first described by Dr James Arnott in 1850 where he used crushed ice and salt to get temperatures as low as -24oC, in the treatment of cervical and breast tumours [1]. The literature on prostatic cryotherapy dates...

The role of embolisation in urology

3 September 2024 | | URO - Functional / Reconstructive Urology, URO - Urologic Oncology
Case 1 An 86–year–old male presented with visible haematuria and suprapubic pain. He had a history of diabetes, heart failure, benign prostatic hypertrophy, aortic valve replacement, deep vein thrombosis (DVT) and atrial fibrillation (AF) and was anticoagulated on a non-VKA...

Remote working: what can health professionals learn from business?

5 February 2021 | | URO - Covid-19
Remote working has been widely used in business for many years but before COVID-19, this was not the case within healthcare settings. This article seeks to review the advantages, challenges and solutions which users of remote working in business have...

Managing sustainability

2 April 2024 |
Planetary health needs to be addressed at a societal level for any meaningful impact to occur. As the global director of sustainability for a law firm, Marion Palmer provides an overview of the responsibilities of corporate organisations for both a...

Management of recurrent cystitis

1 March 2016 | | URO - Infection, URO - Functional / Reconstructive Urology
Acute uncomplicated infective cystitis is most commonly seen in healthy women with a frequency of around 0.5-0.7 episodes per woman per year [1]. Around 10% of women report having had an episode of urinary tract infection (UTI) each year and...

So you want to go on a Fellowship: part 1

1 January 2016 | | URO - Core Urology
Look out for part 2 of this series later in 2016 when the author will discuss settling into the research role of his fellowship and will reflect on his first year overseas. This is the first in a series of...

Lasers in benign prostatic hyperplasia

1 January 2014 | | URO - Functional / Reconstructive Urology, URO - Technology
Clinical benign prostatic hyperplasia (BPH) impacts on the quality of life of many men. It is intimately related to ageing, but exact calculations of its prevalence remain difficult since an accurate clinical definition still eludes us. Histological BPH has been...

Benign prostatic hyperplasia: what are the benefits and harms of various surgical management options?

9 March 2020 | | URO - Functional / Reconstructive Urology, URO - Infection, URO - Neurourology, URO - Technology
Benign prostatic hyperplasia (BPH) is characterised by stromal and epithelial prostatic cell hyperplasia. The enlarged prostate may be associated with voiding and storage lower urinary tract symptoms (LUTS). These have been predominantly attributed to bladder outlet obstruction (BOO), assumed to...

Recent advances in the management of castration resistant prostate cancer

1 November 2017 | | URO - Urologic Oncology
Castrate resistant prostate cancer (CRPC) is defined by disease progression despite androgen-deprivation therapy lowering testosterone to castrate levels. It may present as a rise in serum levels of prostate specific antigen (PSA), progression of pre-existing disease, or the appearance of...